Literature DB >> 21805323

Thrombomodulin and its role in inflammation.

Edward M Conway1.   

Abstract

The goal is to provide an extensive review of the physiologic role of thrombomodulin (TM) in maintaining vascular homeostasis, with a focus on its anti-inflammatory properties. Data were collected from published research. TM is a transmembrane glycoprotein expressed on the surface of all vascular endothelial cells. Expression of TM is tightly regulated to maintain homeostasis and to ensure a rapid and localized hemostatic and inflammatory response to injury. By virtue of its strategic location, its multidomain structure and complex interactions with thrombin, protein C (PC), thrombin activatable fibrinolysis inhibitor (TAFI), complement components, the Lewis Y antigen, and the cytokine HMGB1, TM exhibits a range of physiologically important anti-inflammatory, anti-coagulant, and anti-fibrinolytic properties. TM is an essential cofactor that impacts on multiple biologic processes. Alterations in expression of TM and its partner proteins may be manifest by inflammatory and thrombotic disorders. Administration of soluble forms of TM holds promise as effective therapies for inflammatory diseases, and infections and malignancies that are complicated by disseminated intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805323     DOI: 10.1007/s00281-011-0282-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  273 in total

Review 1.  Activation and silencing of matrix metalloproteinases.

Authors:  Xiaoyun Fu; William C Parks; Jay W Heinecke
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

2.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model.

Authors:  Ellen Vercauteren; Jan Emmerechts; Miet Peeters; Marc F Hoylaerts; Paul J Declerck; Ann Gils
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

Review 5.  C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway.

Authors:  G R Vasta; M Quesenberry; H Ahmed; N O'Leary
Journal:  Dev Comp Immunol       Date:  1999 Jun-Jul       Impact factor: 3.636

6.  Thrombin's effects on osteoblastic cells. I. Cytosolic calcium and phosphoinositides.

Authors:  D N Tatakis; C Dolce; R Dziak
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

7.  Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.

Authors:  Y Gonda; S Hirata; K Saitoh; Y Aoki; M Mohri; K Gomi; T Sugihara; T Kiyota; S Yamamoto; T Ishida
Journal:  Thromb Res       Date:  1993-08-15       Impact factor: 3.944

8.  Phase I study of a novel recombinant human soluble thrombomodulin, ART-123.

Authors:  S Moll; C Lindley; S Pescatore; D Morrison; K Tsuruta; M Mohri; M Serada; M Sata; H Shimizu; K Yamada; G C White
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

9.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

10.  Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block.

Authors:  B Isermann; S B Hendrickson; K Hutley; M Wing; H Weiler
Journal:  Development       Date:  2001-03       Impact factor: 6.868

View more
  99 in total

1.  von Willebrand factor is a cofactor in complement regulation.

Authors:  Shuju Feng; Xiaowen Liang; Michael H Kroll; Dominic W Chung; Vahid Afshar-Kharghan
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

Review 2.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 3.  Thrombotic Regulation From the Endothelial Cell Perspectives.

Authors:  Miao Wang; Huifeng Hao; Nicholas J Leeper; Liyuan Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

Review 4.  Crosstalk between the coagulation and complement systems in sepsis.

Authors:  Florea Lupu; Ravi S Keshari; John D Lambris; K Mark Coggeshall
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

5.  A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption.

Authors:  Amy Moore; Daniel A Enquobahrie; Sixto E Sanchez; Cande V Ananth; Percy N Pacora; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 6.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

7.  Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Yoshimasa Imoto; Atsushi Kato; Tetsuji Takabayashi; Whitney Stevens; James E Norton; Lydia A Suh; Roderick G Carter; Ava R Weibman; Kathryn E Hulse; Kathleen E Harris; Anju T Peters; Leslie C Grammer; Bruce K Tan; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2019-09-25       Impact factor: 10.793

8.  Codon optimized membrane cofactor protein expression in α 1, 3 galactosyltransferase knockout pig cells improve protection against cytotoxicity of monkey serum.

Authors:  Heasun Lee; In-Sul Hwang; Bala Murali Krishna Vasamsetti; Harikrishna Reddy Rallabandi; Mi-Ryung Park; Sung-June Byun; Hyeon Yang; Sun A Ock; Hwi-Cheul Lee; Jae-Seok Woo; Seongsoo Hwang; Keon Bong Oh
Journal:  3 Biotech       Date:  2020-02-10       Impact factor: 2.406

9.  Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia.

Authors:  Qin Yin; Bo Liu; Yunxia Chen; Yunzhou Zhao; Chunsheng Li
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).

Authors:  Friedrich Modde; Putri Andina Agustian; Juliane Wittig; Maximilian Ernst Dämmrich; Vinzent Forstmeier; Udo Vester; Thurid Ahlenstiel; Kerstin Froede; Ulrich Budde; Anne-Margret Wingen; Anke Schwarz; Svjetlana Lovric; Jan Thomas Kielstein; Carsten Bergmann; Nadine Bachmann; Mato Nagel; Hans Heinrich Kreipe; Verena Bröcker; Clemens Luitpold Bockmeyer; Jan Ulrich Becker
Journal:  Virchows Arch       Date:  2013-03-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.